RxDoctor Payments Data

Shawna Smith

Nurse Practitioner · Kent, WANPI 1053307926

Payments from drug & device makers

$2,035in general payments, 2019–2025

Across 53 payments — averaging $38.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$988
  • AbbVie$221
  • Lilly USA, LLC$190
  • Astellas Pharma US Inc$152
  • Mayne Pharma Commercial LLC$141
  • Novo Nordisk$88
  • plus $254 from 6 others

What the payments were for

  • Travel & lodging$98849%
  • Food & beverage$86943%
  • Education$1789%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,035 in reported general payments places this provider in the 90th percentile of 2,466 nurse practitioner providers in Washington.

See all nurse practitioner providers in Washington

Medicare billing

Part B allowed, 2024
$84,120
Medicare patients
117
Services billed
907

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$46,859
JardianceEmpagliflozin30$36,864
EliquisApixaban11$16,997
LinzessLinaclotide12$6,906
Lisdexamfetamine Dimesylate12$3,524
Arnuity ElliptaFluticasone Furoate14$3,245
Rosuvastatin Calcium144$1,736
Omeprazole72$1,694
Gabapentin55$1,642
Olmesartan Medoxomil29$1,462
Levothyroxine Sodium121$1,283
Atorvastatin Calcium119$1,132
Metoprolol Succinate76$1,111
Metformin Hcl ErMetformin Hcl116$1,074
Tramadol Hcl43$994

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$88$46,85933 claims
Boehringer IngelheimJardiance$28$36,86430 claims
PfizerEliquis$68$16,99711 claims
AbbVieLinzess$221$6,90612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,466 nurse practitioner providers in Washington.

Other nurse practitioner in Kent

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →